|
|
Volumn 42, Issue 4, 2010, Pages 1349-1351
|
|
Novel Genetic Mutation in Apolipoprotein E2 Homozygosis and Its Implication in Organ Donation: A Case Report
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTILIPEMIC AGENT;
APOLIPOPROTEIN E2;
ARGININE;
CAPECITABINE;
CHOLESTEROL;
CYCLOSPORIN;
CYSTEINE;
HIGH DENSITY LIPOPROTEIN;
LIPID;
LOW DENSITY LIPOPROTEIN;
PLASMA PROTEIN;
PREDNISONE;
RAPAMYCIN;
SORAFENIB;
TRIACYLGLYCEROL;
ADJUVANT THERAPY;
ADULT;
AGED;
AMINO ACID SUBSTITUTION;
ARTICLE;
BRAIN DEATH;
CANCER SURVIVAL;
CASE REPORT;
CAUCASIAN;
DISEASE SEVERITY;
DONOR SELECTION;
DYSLIPIDEMIA;
FEMALE;
FOLLOW UP;
GENE MUTATION;
GENETIC POLYMORPHISM;
GLOMERULOPATHY;
GRAFT SURVIVAL;
HOMOZYGOSITY;
HUMAN;
HYPERLIPOPROTEINEMIA TYPE 3;
INCIDENCE;
ISOLATED LIVER;
JAPAN;
LIPOPROTEIN GLOMERULOPATHY;
LIVER CELL CARCINOMA;
LIVER FUNCTION;
LIVER GRAFT REJECTION;
LIVER TRANSPLANTATION;
LUNG METASTASIS;
ORGAN DONOR;
PHENOTYPE;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN SYNTHESIS;
AMINO ACID SUBSTITUTION;
APOLIPOPROTEIN E2;
ARGININE;
CEREBRAL HEMORRHAGE;
CYSTEINE;
FEMALE;
HETEROZYGOTE;
HOMOZYGOTE;
HUMANS;
LIVER TRANSPLANTATION;
MIDDLE AGED;
MUTATION;
TISSUE DONORS;
|
|
EID: 77952558849
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2010.03.104 Document Type: Article |
|
Times cited : (8)
|
|
References (5)
|
